Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Wancun Zhang; Lili Xia; Xiangyu Ren; Mengyuan Cui; Tianguang Liu; Chen Ling; Yanqi Xu; Dawei Deng; Xianwei Zhang; Yueqing Gu; Peng Wang

doi:10.1039/D4BM90077D

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Wancun Zhang,^a Lili Xia,^b Xiangyu Ren,^b Mengyuan Cui,^b Tianguang Liu,^b Chen Ling,^b Yanqi Xu,^b Dawei Deng,^b Xianwei Zhang,^a Yueqing Gu^b and Peng Wang*^ab

Author affiliations

* Corresponding authors

^a Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Henan Neurodevelopment Engineering Research Center for Children, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou 450018, China
E-mail: wangpeng159seu@hotmail.com

^b Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, China

Abstract

Correction for ‘The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer’ by Wancun Zhang et al., Biomater. Sci., 2020, 8, 5941–5954, https://doi.org/10.1039/D0BM01035A.

Biomaterials Science

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Social activity

Search articles by author

Spotlight

Advertisements